Neurosciences and Sense Organs

This is perhaps the oldest research area of the Ramón y Cajal Hospital. Since its inception, translational research in the field of Neurology and of Neurosciencesin general, has played a prominent role in the research activity of the hospital and currently constitutes the largest research area of IRYCIS.

Leaders

  • Dr. Francisco Muñoz Negrete

    Dr. Francisco Muñoz Negrete

    Dr. FRANCISCO J. MUÑOZ NEGRETE is the Head of the Ophthalmology Service at the University Hospital Ramón y Cajal (Madrid, Spain), MRS 2014 and 2015: Best reputation of Ophthalmology Services in Spain, and Full Professor Ophthalmology at Universidad Alcalá.

    Dr. Muñoz Negrete graduated in Medicine at the Medical School of the University of Granada, in 1983 (First prize) and obtained his PhD at the University of Alcalá in 1994. He completed his residency in Ophtalmology at Ramón y Cajal University Hospital in Madrid, in 1988.

    He leads the "Ophtalmology" research group at Institute Ramón y Cajal for Health Research (IRYCIS) in which he coordinates the Neuroscience and Sense Organs Area (Area 1). His research activity has been recognized with the Prize for Excelence Research in Glaucoma (2011, 2016) and he is part of the Spanish Network of Ocular Diseases; RETICs "OFTARED". His h-factor is 20, which accounts for 111 indexed publications, 3 full books and 42 book chapters. He is the supervisor of 25 thesis. He has lead 11 national research projects and 27 clinical trials and he is the inventor of 1 international patent for an ocular device.

    Currently he is the Vicepresident of the Spanish Glaucoma Society (SEG), Treasurer of the Ophthalmologic Society of Madrid and Editor in chief of Archives of the Spanish Society of Ophtalmology. 

    Close

    Dr. Francisco Muñoz Negrete

    Head of the ophthalmology service

    See CV
  • Dr. Javier Fernández Ruiz

    Dr. Javier Fernández Ruiz

    JAVIER FERNÁNDEZ-RUIZ is a PhD in Biochemistry obtained in 1986 in the Complutense University, Madrid, Spain. He is currently Full Professor in the Department of Biochemistry and Molecular Biology, Faculty of Medicine, in such university, and director of such department section since May 2018. Together with his teaching activities in the areas of Neurochemistry and Neurobiology, both in Degree and Master, he has been working during the last 38 years in different diseases of the Central Nervous System, having authored 235 research articles and 43 review articles in international journals, with a H-index of 68. Also 42 chapters in national and international books and 7 international patents. He has given lectures at different national and international universities and research centers, as well as numerous presentations at national and international congresses.

    He is currently the Principal Investigator of the "Cannabinoids and Neurological Disorders" research group at the Complutense University, and also at two cooperative networks of excellence research in Spain: CIBERNED and IRYCIS. His group has collaborations with several national and international groups, and five pharmaceutical companies: GW Pharma, Emerald Health Pharmaceuticals, VivaCell Biotechnology Spain, Roche and Symrise. He has participated in numerous research projects, acting as PI in many of them, including 7 research contracts with pharma companies. He has acted as reviewer for journals such as Annals of Neurology, Biological Psychiatry, Brain, FASEB Journal, FEBS Letters, Glia, Journal of Neuroscience, Nature Reviews Neuroscience, Neurobiology of Disease, Neuropharmacology, Neuroscience, PNAS, Trends in Pharmacological Sciences and others. He has been a member, representing the UCM, in the IRYCIS Governor Committee (2011-2017), and is currently a member in the Scientific Advisor Committee of the pharma companies Emerald Health Biotechnology-Spain and Linneo Health (formerly Alcaliber), and a member of the Editorial Board in the British Journal of Pharmacology. He has been President of the International Cannabinoid Research Society (ICRS) (2002-2003) and member of its Executive Committee (2001-2004), as well as a founding member of the Spanish Cannabinoid Research Society (SEIC) and member of its Executive Committee (2000-2013) serving as President during 2007-2011.

    Close

    Dr. Javier Fernández Ruiz

    Professor Complutense University of Madrid

    See CV